SERIOUS side effects which may occur when drugs are taken for short periods are readily publicized, but an insidious, cumulative toxicity accompanying the chronic use of drugs for months or years may not be so readily apparent. Such may be the case with the psychotropic drugs in widespread use today, namely, the phenothiazines and the -Cpsychoenergizers" such as imipramine and related compounds. The drugs play an important role in the management of serious psychoneurotic and psychotic disorders. They are credited, especially in anxiety, schizophrenia, and severe depression, with changing the dismal prognosis and the long-term incarceration in mental institutions of past years.
The total medical needs of institutionalized patients are readily overlooked, and it would not be surprising that manifestations of drug toxicity might go unrecognized. In such a setting, Richardson and associates' reported sudden deaths implicating tranquilizers as the cause. Histological and histochemical techniques demonstrated acid mucopolysaccharide material in and around the arteriocapillary bed, particularly in the subendocardial region. It is assumed that such changes might be the basis for the abnormal electrocardiograms found in patients taking phenothiazines as reported by Ban and St. Jean2 and for the abnornal electrocardiographic changes, both clinically and experimentally, in acute poisoning with imipramine or its analogs observed by Gaultier and associates.3 Like the phenothiazines, disturbed A-V and I-V conduction were commonly encountered. A considerable variation in species susceptibility-LD5o calculated for man being only one tenth the LD50 for mice (40 mg/kg vs. 400 mg/kg) -was reported. 1014 From the literature I gained the impression that electrocardiographic abnormalities and cardiac toxicity are reversible when administration of the drugs is stopped, but my experience leads me to a contrary conclusion: namely, that the damage to the heart can be serious and permanent.
Considering the large number of patients in institutions taking the drugs on a chronic basis and without detailed evaluations of their cardiovascular status, the true prevalence of cardiac toxicity is unknown. Isolated reports in neuropsychiatric journals, as exemplified by the report of Leestma and Koenig,4 constitute the main source of information regarding the possible hazards. It is suggested that each patient to whom phenothiazines or imipramine-type drugs is chronically administered, have a cardiological evaluation including a chest x-ray and electrocardiogram periodically, at least at 6month intervals. The appearance of abnormal electrocardiographic changes or evidence of cardiomegaly requires reappraisal of the neuropsychiatric situation and judgment whether it is severe enough to justify the continued use of a possibly life-threatening cardiotoxic drug. In a search of the literature in relation to acute and chronic toxicity, I found no report on the effect of prolonged administration (6 months or longer) of these drugs in animals. Man, himself, serves as the experimental subject. 
